Nanomaterials for Bioimaging
2025 Activity indicators
- 11 competitive national public projects: MICINN, CAM
- 5 competitive HR contracts
- 12 publications
- FI: 115.10
- Publications in Q1: 11 (92%)
- Publications in D1: 7 (58%)
- 3 doctoral theses supervised and defended
- 1 award
- Evaluators for public agencies: 2 PI and 2 researchers
- Editorial committee members: 4 researchers
- 1 student hosted and 14.7-month stay: Quaid-I-Azam University, Islamabad (Pakistan)
Milestones
- Publication in Nature Communications: Ming L, Romelli A, Lifante J, Canton P, Lifante G, Jaque D, Ximendes E, Marin R. Luminescence-enabled three-dimensional temperature bioimaging. Nat Commun. 2025;16(1): 6429-6429. DOI:10.1038/s41467-025-59681-7.
- The group has achieved success in participating in European funding calls, securing funding under the HORIZON-MSCA-2025-PF call within the Marie Skłodowska-Curie Actions (out of more than 17,000 applicants, 9.6% success rate). This project, which will allow Dr. Fernando Maturi to join the group, aims to integrate near-infrared imaging, 3D bioprinting, and machine learning to improve tumor margin detection.
- Francisco Sanz was promoted to full professor, the highest level in the university career, in recognition of his outstanding academic record.
- Leyre Aldaz, Liyan Ming, and Mario de la Fuente successfully defended their doctoral theses on the development of nanothermometry in tissues, the synthesis and characterization of sulfur-based nanomaterials for sensor applications, and the metabolic and cardiovascular effects of tea extracts, thus reflecting the broad scope of research covered at nanoBIG.
- A fluorescence half-life imaging (FLIM) microscopy system was implemented in the visible and near-infrared (NIR) regions.
Bibliometrics
| Articles | Accum. FI | Mean FI | Articles Q1 or Q2 | % in Q1 or Q2 | Articles D1 | % in D1 | |
|---|---|---|---|---|---|---|---|
| 2021 | 13 | 197.60 | 15.20 | 11 | 85 | 7 | 54 |
| 2022 | 20 | 175.12 | 8.76 | 16 | 80 | 6 | 30 |
| 2023 | 15 | 159.90 | 12.30 | 13 | 87 | 6 | 40 |
| 2024 | 9 | 47.90 | 5.32 | 7 | 78 | 1 | 11 |
| 2025 | 12 | 115.10 | 9.59 | 12 | 100 | 7 | 58 |
| 69 | 695.62 | 9.91 | 59 | 86 | 27 | 39 |
* Only original articles, editorials, guidelines and reviews